Celanese (CE)
Makes specialty materials through Engineered Materials and Acetyl Chain.
$47.44
After hours0.00 (0.00%)
At close$47.44(+6.89%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,723 | 2,569 | 2,611 | 2,651 | 2,648 | 2,370 | 2,389 | 2,532 | 2,419 | 2,204 | 2,337 | 2,752 |
| Cost of revenue | 2,050 | 1,956 | 2,057 | 2,010 | 2,026 | 1,831 | 1,913 | 1,997 | 1,898 | 1,821 | 1,894 | 2,134 |
| Gross profit | 673 | 613 | 554 | 641 | 622 | 539 | 476 | 535 | 521 | 383 | 443 | 618 |
| −169 | 354 | 344 | 391 | 374 | 1,944 | 308 | 302 | 1,796 | 255 | 254 | 342 | |
| Research & development | 32 | 32 | 34 | 33 | 32 | 31 | 31 | 31 | 31 | 32 | 28 | 29 |
| 244 | 272 | 265 | 255 | 248 | 262 | 230 | 213 | 231 | 223 | 226 | 251 | |
| Selling & marketing | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 244 | 0 | 0 | 253 | 248 | 0 | 0 | 213 | 0 | 0 | 0 | 251 |
| Other expenses | −445 | 50 | 45 | 103 | 94 | 1,651 | 47 | 58 | 1,534 | 0 | 0 | 62 |
| Operating income | 842 | 259 | 210 | 250 | 248 | −1,405 | 168 | 233 | −1,275 | 128 | 189 | 276 |
| −128 | −127 | −53 | −67 | −65 | −114 | −171 | −98 | −85 | −115 | −107 | −134 | |
| Interest income | 12 | 12 | 13 | 10 | 5 | 5 | 4 | 7 | 7 | 6 | 9 | 10 |
| Interest expense | 183 | 178 | 169 | 174 | 169 | 164 | 201 | 177 | 177 | 214 | 183 | 186 |
| Other non-operating income | −50 | −50 | −116 | −107 | −104 | −50 | 1 | −79 | −92 | −99 | −76 | 42 |
| Income before tax | 714 | 132 | 157 | 183 | 183 | −1,519 | −3 | 135 | −1,360 | 13 | 82 | 142 |
| Income tax expense | −236 | −575 | 33 | 29 | 61 | 387 | 9 | −77 | −7 | −15 | 33 | 11 |
| Net income from continuing operations | 950 | 707 | 124 | 154 | 122 | −1,906 | −12 | 212 | −1,353 | 28 | 49 | 131 |
| Discontinued operations | −1 | −6 | 0 | −1 | −2 | −5 | −5 | −10 | 0 | −6 | −1 | −2 |
| Net income | 951 | 698 | 121 | 155 | 116 | −1,914 | −21 | 199 | −1,357 | 19 | 44 | 125 |
| EPS, basic | $8.73 | $6.40 | $1.11 | $1.42 | $1.06 | −$17.50 | −$0.19 | $1.82 | −$12.39 | $0.17 | $0.40 | $1.14 |
| EPS, diluted | $8.69 | $6.37 | $1.10 | $1.41 | $1.06 | −$17.50 | −$0.19 | $1.81 | −$12.39 | $0.17 | $0.40 | $1.13 |
| Weighted average shares, basic | 109 | 109 | 109 | 109 | 109 | 109 | 109 | 110 | 110 | 110 | 110 | 110 |
| Weighted average shares, diluted | 109 | 110 | 110 | 110 | 110 | 109 | 109 | 110 | 110 | 110 | 110 | 110 |
| EBITDA | 1,077 | 483 | 553 | 555 | 561 | −1,166 | 358 | 505 | −982 | 411 | 473 | 273 |
| Depreciation & amortization | 185 | 174 | 227 | 198 | 209 | 189 | 191 | 193 | 201 | 184 | 208 | 39 |
| EBIT | 892 | 309 | 326 | 357 | 352 | −1,355 | 167 | 312 | −1,183 | 227 | 265 | 234 |
